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Background: Cudrania tricuspidata extract is an important traditional herbal remedy for tumors, inflammation,
gastritis, and liver damage and is predominantly used in Korea, China, and Japan. However, the anti-inflammatory
effects of the extract have not yet been conclusively proved.
Methods: In this study, we investigated the effects of the CHCl3 fraction (CTC) of a methanol extract of C.
tricuspidata on the lipopolysaccharide (LPS)-induced nitric oxide (NO) and prostaglandin E2 (PGE2) production in
RAW 264.7 macrophage cells and mouse peritoneal macrophages, and the levels of pro-inflammatory cytokines
tumor necrosis factor-α (TNF-α), interleukin (IL)-1β and IL-6 in RAW 264.7 macrophage cells.
Results: We observed that the protein expression levels of inducible NO synthase and COX-2 enzymes were
markedly inhibited by CTC in a concentration-dependent manner. In addition, CTC reduced the production of
TNF-α, IL-1β, and IL-6 in the LPS-stimulated RAW 264.7 macrophage cells.
Conclusions: Our results show that the C. tricuspidata extract could modulate macrophage-mediated inflammatory
functions such as the overproduction of cytokines, NO, and PGE2. The CTC was found to be the active fraction in
this context.
Keywords: Cudrania tricuspidata, Nitric oxide, Prostaglandin E2, Lipopolysaccharide CHCl3 partitioned methanol
extract of Cudrania tricuspidata, CTC, Lipopolysaccharide, LPS, prostaglandin E2, PGE2, nitric oxide, NOBackground
Inflammation is the result of the host’s immune response
to pathogenic challenges or tissue injuries, and under
normal conditions, tissue structure and function are
restored to normal when the response ends. Moreover,
normal inflammatory responses are self-limited by a
process that involves the downregulation of pro-
inflammatory proteins and the upregulation of anti-
inflammatory proteins [1]. Thus, acute inflammation is
essentially a beneficial process, particularly in response
to infectious pathogens, whereas chronic inflammation
is an undesirable phenomenon that can lead to inflam-
matory diseases [2].* Correspondence: hychoi@khu.ac.kr
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reproduction in any medium, provided the orMacrophages are extraordinarily versatile cells, and
the ability of the macrophages to exploit their full func-
tional repertoire is essential for host immunity [3].
Macrophages detect pathogenic substances through
pattern-recognition receptors and subsequently initiate
and regulate inflammatory responses [3] by using a wide
range of soluble pro-inflammatory mediators. Lipopoly-
saccharide (LPS) is one of the most powerful activators
of macrophages, and macrophages and monocytes that
have been activated by LPS are known to produce in-
flammatory mediators such as nitric oxide (NO) and
other free radicals, in addition to numerous cytokines
such as tumor necrosis factor-α (TNF-α), interleukin
(IL)-1β, and IL-6 [4-6]. Bacterial pathogens, like LPS,
activate cytokine networks by inducing many pro-
inflammatory genes. Moreover, these inductions ared. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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tors [7]. During the inflammatory process, large amounts
of the pro-inflammatory mediators NO and prostaglan-
din E2 (PGE2) are generated by the inducible isoforms of
NO synthase (NOS) and cyclooxygenase-2 (COX-2) [8].
In mammalian cells, NO is synthesized by 3 isoforms of
NOS, namely, neuronal NOS (nNOS), endothelial NOS
(eNOS), and inducible NOS (iNOS). Although nNOS
and eNOS are constitutively expressed, iNOS is specific-
ally expressed in response to interferon-γ (IFN-γ), LPS,
and various pro-inflammatory cytokines [9,10]. Several
studies have suggested that the overexpression of COX-2
or iNOS is intimately involved in the pathogenesis of in-
flammation, cancer, multiple sclerosis, Parkinson’s syn-
drome, Alzheimer’s disease [11], and other diseases.
Thus, many efforts have been made to develop enzyme
inhibitors or repressors of enzyme formation that select-
ively target the inducible forms of these enzymes and, in
particular, do not affect the activities of their respective
constitutive isoforms. Therefore, inhibiting the produc-
tion of NO and PGE2 is an important therapeutic target
in the development of anti-inflammatory agents.
Cudrania tricuspidata (CT) is a deciduous tree dis-
tributed across South Korea, China, and Japan, and the
cortex and root bark of CT have been frequently used as
a traditional medicine to treat inflammation and tumors
[12]. Several previous reports have described various
effects of the CT extract, which include antioxidant ac-
tivity [13], inhibitory effect on NOS [14], and effects on
the proliferation of inflammatory immune cells and
tumor cells [15,16]. However, no studies to date have
investigated the effects of the CHCl3 fraction (CTC) of
the methanol extract of CT on inflammatory reactions.
In the present study, we show that CTC reduces the
production of NO, PGE2, and TNF-α in RAW 264.7
cells and mouse macrophage cells when these cells are
treated with recombinant LPS.
Methods
Plant materials
Non-cultivated CT was collected from the Chiri Moun-
tain in the far south of the Republic of Korea. Collection
was made on February 20, 2007, a time when the plants
have many thorns and few leaves. The plant materials
were identified by Professor Ho-Young Choi at the Her-
bology Laboratory, College of Oriental Medicine, Kyun-
ghee University, Seoul. Fresh CT was removed using a
sickle and dried in a dark, well-ventilated place. Air-dried
CT (1 kg) was cut into pieces by using a fodder chopper,
and the extract was prepared by incubating with 80%
methanol at room temperature for several days. Then the
CT methanol extract (CTM) was fractionated using
CHCl3, and the CHCl3 extracts were evaporated to afford
a CHCl3-soluble (14 g) fraction (CTC), which wasdissolved in DMSO (Sigma, St. Louis, MO, USA) to ob-
tain a final concentration of 100 mg/ml, and was stored
at −20°C until required. To use, the extract was further
diluted to different concentrations by using cell culture
media (DMSO < 0.1%).
Animals
Male BALB/c mice (6–8 weeks of age) were purchased
from the Korean branch of Taconic, Samtaco (Osan,
Korea). Mice were kept in a temperature- and humidity-
controlled, pathogen-free animal facility at Kyung Hee
University and provided standard mouse chow and water
ad libitum. All animal care and experimental procedures
were complied with university guidelines of by Korean
National Veterinary Research and Quarantine Service,
World Organization of Animal Health (WOAH) and
were approved by the Ethical Committee for Animal
Care and the Use of laboratory animals Kyung Hee
University (Approval number # KHUASP(SE)-11-039).
Cell culture and sample treatment
RAW 264.7 cells were obtained from the Korean Cell Line
Bank (Seoul), and were grown at 37°C in DMEM medium
supplemented with 10% FBS, penicillin (100 units/ml),
and streptomycin sulfate (100 mg/ml) in a humidified 5%
CO2 atmosphere. Cells were incubated with CT at increas-
ing concentrations (62, 125, 250, and 500 mg/ml), and
then stimulated with LPS (1 or 10 μg/ml) for the indicated
times.
Macrophage isolation and culture
Mice were injected intraperitoneally (i.p.) with 2 ml
of sterile thioglycollate medium (Becton Dickinson,
Franklin Lakes, NJ, USA). Three days later, macrophages
were collected by peritoneal lavage with cold Dulbecco’s
modified Eagle’s medium (DMEM). After centrifugation
of the lavage, red blood cells were removed by lysis for
3 min in lysis buffer (150 mM NH4Cl, 1 mM KHCO3,
and 0.1 mM Na2EDTA). After centrifugation, the cells
were resuspended in DMEM supplemented with 1%
antibiotic and antimycotic solution (Invitrogen, Carls-
bad, CA, USA) and 10% fetal bovine serum (WeIGENE,
Deagu, Korea), then incubated for 90 min in a humidi-
fied atmosphere of 5% CO2 at 37°C. Non-adherent cells
were removed by washing, and the adherent cells were
harvested and seeded for the various assays.
MTS-tetrazolium salt assay
Cell viability was measured based on the formation of
blue formazan metabolized from colorless MTS by mito-
chondrial dehydrogenases, which are active only in live
cells. RAW 264.7 macrophages were plated in 96-well
plates at a density of 4 × 103 cells per well for 24 h, and
then washed. Cells incubated with various concentrations
Figure 1 Effect of CTM on the viability of LPS-stimulated RAW
264.7 cells. Cells (5 × 104) were incubated with CTM and CTC
(62, 125, 250, 500 μg/ml) at 37°C for 24 h. Cell viabilities were
evaluated using MTS assays. Data represent the means ± SDs of
three independent experiments.
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Sigma, MO, USA) for 24 h and then incubated in
0.5 mg/ml MTS solution. Viabilities were determined
using colorimetric MTS assay.
Determinations of nitrite concentrations
RAW 264.7 cells were plated at 2.5 × 105 cells/ml in 24
well-plates and then incubated with or without LPS
(1 μg/ml) in the absence or presence of various concen-
trations (62, 125, 250 and 500 μg/ml) of CTC for 24 h.
The nitrite accumulated in culture medium was mea-
sured as an indicated of NO production based on the
Griess reaction. Briefly, 100 μl of cell culture medium
was mixed with 100 μl of Griess reagent [equal volumes
of 1% (w/v) sulfanilamide in 5% (v/v) phosphoric acid
and 0.1% (w/v) naphtylethylenediamine-HCl], incubated
at room temperature for 10 min, and then the absorb-
ance at 540 nm was measured in a microplate reader
(VersaMax™, Molecular Device, USA). Fresh culture
medium was used as the blank in all experiments. The
amount of nitrite in the samples was measured with the
serial dilution standard curve of sodium nitrite.
Western blot analysis
Cellular proteins were extracted from control and CT-
treated RAW 264.7 cells. Briefly, cells were collected by
centrifugation and the pellets so obtained were washed
once with phosphate-buffered saline (PBS). Pellets were
then resuspended in extraction lysis buffer (50 mM
HEPES pH 7.0, 250 mM NaCl, 5 mM EDTA, 0.1% Noni-
det P-40, 1 mM phenylmethylsulfonyl fluoride, 0.5 mM
dithiothreitol, 5 mM Na fluoride and 0.5 mM Na ortho-
vanadate) containing 5 mg/ml leupeptin and 5 mg/ml
aprotinin and incubated for 20 min at 4°C. Cell debris
was removed by microcentrifugation, and supernatants
were rapidly frozen. Protein concentrations were deter-
mined using the Bio-Rad protein assay reagent
(Hercules, CA), according to the manufacturer’s instruc-
tions. Proteins (40 μg) were separated by 10% SDS-
polyacrylamide gel electrophoresis, and electroblotted
onto nitrocellulose membranes. Immunoblots were incu-
bated overnight with blocking solution (5% skimmed
milk) at 4°C, and then for 4 h with a primary antibody.
Blots were then washed three times with Tween 20/Tris-
buffered saline (TBST), incubated in 1:100 alkaline
phosphatase-conjugated secondary antibody for 1 h
at room temperature, washed three times with TBST,
and finally reacted with BCIP-NBT solution (Nakanai
Tesque, Japan). The monoclonal antibodies (iNOS,
COX-2 and β-actin), and the peroxidase-conjugated sec-
ondary antibody were purchased from Santa Cruz Bio-
technology, Inc. (Santa Cruz, CA, USA). Density ratios
versus β-actin were determined by densitometry analysis
(Scion NIH Image 1.63).Measurement of PGE2 levels
PGE2 levels in culture media were analyzed using PGE2
assay kits (ParameterTM; R&D Systems, MN, USA). The
PGE2 standard and the RD5-39 in the kits were used
to construct a standard curve. Briefly, 100 μl of the
medium was mixed with 50 μl of primary antibody so-
lution and PGE2 conjugate and incubated for 2 h at
room temperature on a shaker. Cells were then washed
out of wells using 400 μl of 1× washing buffer; then,
color reagent (200 μl) was added and, 30 min later,
stop solution (50 μl) was added and mixed in. Absorb-
ance was measured at 450/570 nm using a VersaMaxTM
microplate reader (Molecular Devices, CA, USA).
Cytokine array assays
Mouse cytokine antibody array membranes coated with
40 specific cytokine antibodies (RayBioTM Mouse In-
flammation Antibody Array 1, RayBiotech, Inc.) were
probed with isolated total protein samples. The mem-
branes were blocked by incubation in blocking buffer for
30 min at room temperature and then incubated with
samples for 1 h at room temperature. Membranes were
then washed three times with Wash Buffer I and twice
with Wash Buffer II for 5 min at room temperature per
wash and then incubated with biotin-conjugated anti-
bodies at 4°C overnight. Membranes were then washed,
incubated with HRP-conjugated streptavidin for 1 h at
room temperature, incubated with detection buffer for
1 min, and exposed to X-ray film for 40 s (Kodak Inc.).
Exposed films were digitized and relative cytokine levels
were determined by densitometry (Scion NIH Image
1.63), by subtracting background staining level and nor-
malizing to positive control spots, which were used as
internal standards.
Figure 2 Effect of CTM on LPS-induced NO levels in RAW 264.7 cells. (A) Cells were treated with different concentrations of CTM and CTC
(62, 125, 250, 500 μg/ml) for 1 h, then with LPS (10 μg/ml) for 24 h. Culture supernatants were subsequently isolated and analyzed for nitrite
levels. (B) Nitrite levels in culture supernatants were measured after macrophages (2 × 106 cells/ml) were primed with IFN-γ (0.5 ng/ml) for 2 h
and then stimulated with LPS (1 μg/ml) in the presence of CTM and CTC for 18 h. Values are means ± SDs of three separate experiments.
(#p < 0.05 vs. the non-treated control group; *p < 0.05, **p < 0.01 vs. the LPS-treated group).
Figure 3 Effect of CTM on LPS-induced PGE2 production in RAW 264.7 cells. (A) PGE2 production was measured in RAW 264.7 cells treated
with different concentrations of CTM and CTC (62, 125, 250, 500 μg/ml) for 1 h, then incubated with LPS (10 μg/ml) for 24 h. (B) PGE2 production
in culture supernatants was measured after macrophages (2 × 106 cells/ml) were primed with IFN-γ (0.5 ng/ml) for 2 h and then stimulated with
LPS (1 μg/ml) in the presence of CTM and CTC for 18 h. Values are means ± SDs of three separate experiments. (#p < 0.05 vs. the non-treated
control group; *p < 0.05, **p < 0.01 vs. the LPS-treated group).
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The results shown were obtained from at least three in-
dependent experiments and are presented as means ±
SDs. Statistical analyses were performed by one-way ana-
lysis of variance (ANOVA) with Tukey’s and Duncan’s
post hoc tests. All statistical analyses were performed
using SPSS v12.0 software. P values < 0.05 were consid-
ered to indicate statistical significance.Results
Effects of CTC on the viability of RAW 265.7 cells
We examined the effects of CTM on the viability of
RAW 264.7 cells in vitro by incubating cells with 62 μg/
ml, 125 μg/ml, 250 μg/ml, or 500 μg/ml of CT or CTC
for 24 h. The results of the MTS assay showed that CT
and CTC were not cytotoxic to RAW 264.7 cells at con-
centrations up to 500 μg/ml (Figure 1).Figure 4 Effect of CTC on LPS-induced iNOS and COX-2 protein levels
concentrations of CTC (125, 250, 500 μg/ml) for 1 h and then with LPS (10
(B) Relative expression of iNOS and COX-2. Bands on western blots were q
of at least three independent experiments (#p < 0.05 vs. the non-treated coEffects of CTC on LPS-induced NO and PGE2 production
To investigate the anti-inflammatory properties of
CTC, we used RAW 264.7 cells, which produce NO
and PGE2 when stimulated by LPS. The cells were pre-
incubated with varying concentrations of CTM and
CTC (each at 62 μg/ml, 125 μg/ml, 250 μg/ml, and
500 μg/ml) for 1 h and then stimulated with 10 μg/ml
LPS for 24 h. LPS and CT were not added to the
controls (Con). The nitrite and PGE2 levels in the
media were determined, and we observed that CTC
reduced NO and PGE2 production in a dose-
dependent manner (Figures 2A and 3A). To examine
the potential effects of CTC on LPS-induced NO and
PGE2 production in macrophages, the cells were pre-
treated with IFN-γ (0.5 ng/ml) for 2 h and then
stimulated with LPS (1 μg/ml) and varying concentra-
tions of either CTM or CTC (62 μg/ml, 125 μg/ml,
250 μg/ml, and 500 μg/ml each) for 18 h. The NOin RAW 264.7 cells. (A) Cells were treated with different
μg/ml) for 24 h. β-actin expression is shown as a loading control.
uantified by densitometry. The values are expressed as the means ± SD
ntrol group; *p < 0.05, **p < 0.01 vs. the LPS-treated group).
Yang et al. BMC Complementary and Alternative Medicine 2012, 12:250 Page 6 of 7
http://www.biomedcentral.com/1472-6882/12/250and PGE2 concentrations in the culture supernatants
were suppressed by CTC in a dose-dependent manner
(Figures 2B and 3B).Effects of CTC on LPS-induced iNOS and COX-2 protein
Levels
Western blotting was performed to determine whether the
inhibitory effects of CTC on NO and PGE2 production
were related to the changes in the expressions of iNOS
and COX-2. LPS markedly upregulated iNOS and COX-
2 protein levels, and pre-treatment with CTC inhibited
these upregulations (Figure 4). These results indicate that
the inhibitory effects of CTC on LPS-induced NO and
PGE2 production are due to the suppression of iNOS
and COX-2.Effects of CTC on the LPS-induced production of TNF-α,
IL-1β, and IL-6
The effects of CTC on LPS-induced TNF-α, IL-1β, and
IL-6 release were investigated using a cytokine array. We
observed that pretreatment of RAW 264.7 cells with
CTC (250 μg/ml) decreased the TNF-α, IL-1β, and IL-6
production (Figure 5).Figure 5 Effect of CTC on LPS-induced cytokine expression in RAW 26
monitored 24 h after treating cells with LPS (10 μg/ml) with or without CTDiscussion
The present study was undertaken to elucidate the
pharmacological and biological effects of CTC on the
production of inflammatory mediators in RAW 264.7
macrophages. The results indicate that CTC is an effect-
ive inhibitor of LPS-induced NO, PGE2, TNF-α, IL-1β,
and IL-6 production in these cells. Furthermore, these
inhibitory effects of CTC were accompanied by dose-
dependent decreases in the protein levels of iNOS and
COX-2. These findings indicate that the expression of
iNOS and COX-2 in RAW 264.7 cells is suppressed by
CTC, and that this suppression leads to the downregula-
tion of NO and PGE2.
NO is a key inflammatory mediator, and excessive NO
production occurs in both acute and chronic inflamma-
tion. NO is synthesized from L-arginine by NOS isoen-
zymes, one of which is iNOS, which is expressed
predominantly in activated macrophages [17]. Similarly,
PGE2 is a well-known inflammatory mediator produced
by the action of COX-1 and COX-2 on arachidonic acid.
COX-2 expression is induced by cytokines, LPS, and
other activators during inflammation, resulting in the
release of high levels of PGE2 at the sites of inflammation
[18]. In this study, we showed that in LPS-stimulated4.7 cells. Levels of the cytokines TNF-α, IL-1β and IL-6 were
C.
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PGE2 production. The levels of iNOS and COX-2 were
also downregulated by CTC, suggesting that this was the
mechanism underlying the observed suppression of NO
and PGE2 production.
LPS stimulates macrophages to produce iNOS, COX-2
and pro-inflammatory cytokines such as TNF-α, IL-1β,
and IL-6 [17]. In addition, these pro-inflammatory med-
iators play important roles in the pathogenesis of various
acute and chronic inflammatory diseases. Thus, blocking
the effects of pro-inflammatory mediators could be an
effective therapeutic strategy. Inflammatory disorders are
characterized, among other events, by the production of
significant amounts of free radicals, nitrogen reactive
species, and cytokines such as TNF-α, IL-1β, and IL-6
[18]. TNF-α is a critical cytokine in the inflammatory
cytokine network; it can induce the release of IL-1β
and IL-6, which in turn enhances the sensitivity of the
tissue macrophages to TNF-α. TNF-α is an endogen-
ous pyrogen that can cause fever and stimulate the
endotheliocytes and leukocytes to release a series of
inflammatory mediators (NO, oxyradicals, etc.) that
may further promote TNF-α production [19]. TNF-α
plays an important role in the pathological damage
associated with inflammation. Our results show that
CTC significantly suppresses the production of IL-1β,
IL-6, and TNF-α, suggesting that CTC exerts its anti-
inflammatory effects via inhibition of IL-1β, IL-6, and
TNF-α production.
Conclusions
In summary, the results of the present study show that
the anti-inflammatory effects of CTC are achieved via
the modulation of macrophage-mediated inflammation-
associated functions such as the overproduction of cyto-
kines, NO, and PGE2. Moreover, the described CHCl3
fraction was found to be the active fraction in this
context.
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